yeztugo lenacapavir - Search News

News

HIV prevention drug lenacapavir approved by FDA

6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts say lenacapavir is easier to administer, and each dose lasts longer compared to other medications.

TIME on MSN · 2d

FDA Approves a Twice-Yearly Shot to Prevent HIV

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

Wired · 11h

The FDA Just Approved a Long-Lasting Injection to Prevent HIV

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.

Everyday Health on MSN2h

FDA Approves a ‘Game-Changing’ Twice-a-Year HIV Prevention Shot

The new HIV PrEP option could drastically reduce the number of new cases by offering a new alternative to daily pills or every-other-month injections.

MPR7h

Twice-Yearly HIV-1 PrEP Yeztugo Gets FDA Approval

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Managed Healthcare Executive1d

Lenacapavir HIV PrEP: Not an AIDS Vaccine, but Vaccine Adjacent

Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results